We are looking for 2 to 17 years old to join a study to help us discover more about treating moderately to severely active IBD. If you are looking for a potential new treatment option for moderately to severely active IBD or moderate to severe CD (including associated symptoms such as abdominal pain or cramping, joint pain, diarrhea, weight loss and/or canker sores), consider one of our CD studies. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years old may be eligible to take part.
Your child may be eligible to take part in the CD studies if they:
- are 2‒17 years of age
- have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
- have previously received treatment for UC or CD that has not worked.
Find out if your child qualifies.
